Leucovorin Calcium Tablet
NDC Package 0904-7584-10
Package Information
Leucovorin Calcium tablets is a medication used to treat or prevent serious blood cell disorders (such as thrombocytopenia, neutropenia, anemia) caused by certain drugs (folic acid antagonists such as methotrexate, trimethoprim, pyrimethamine). This formulation utilizes a tablet delivery system. Marketed by Major Pharmaceuticals, this product is identified by NDC 0904-7584 and is authorized under FDA application ANDA211132.
Identification & Billing
- RxCUI: 197862 - leucovorin calcium 25 MG Oral Tablet
- RxCUI: 197862 - leucovorin 25 MG Oral Tablet
- RxCUI: 197862 - leucovorin 25 MG (as leucovorin calcium 27.01 MG) Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0904 - Major Pharmaceuticals
- 0904-7584 - Leucovorin Calcium
- 0904-7584-10 - 20 BLISTER PACK in 1 CARTON / 1 TABLET in 1 BLISTER PACK
- 0904-7584 - Leucovorin Calcium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0904-7584-10 identifies a specific commercial package of 20 blister pack in 1 carton / 1 tablet in 1 blister pack of Leucovorin Calcium, a human prescription drug labeled by Major Pharmaceuticals. This tablet is formulated for oral use and contains leucovorin calcium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Major Pharmaceuticals on March 27, 2026. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to treat or prevent serious blood cell disorders (such as thrombocytopenia, neutropenia, anemia) caused by certain drugs (folic acid antagonists such as methotrexate, trimethoprim, pyrimethamine). It may also be used with a certain cancer drug (5-fluorouracil) to treat patients with colon cancer. Leucovorin may also be used to treat a certain type of anemia (due to folic acid deficiency) when folic acid cannot be taken by mouth.
How is this Major Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00904758410. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.